Dian Diagnostics Group Co Ltd is committed to upholding strong values and a robust corporate philosophy. The company embodies a customer-centric approach, prioritizing excellence and innovation in providing diagnostic solutions and medical services. Dian Diagnostics Group Co Ltd places great importance on quality, accuracy, and efficiency, ensuring customers receive reliable diagnostic results. With a focus on continuous improvement, the company utilizes cutting-edge technology and a dedicated team of professionals to deliver superior healthcare solutions. Dian Diagnostics Group Co Ltd strives for integrity, transparency, and trustworthiness in all aspects of its operations, establishing itself as a trusted leader in the diagnostic industry.

Dian Diagnostics Group Co Ltd is primarily present in China.

Dian Diagnostics Group Co Ltd has achieved several significant milestones in its history. The company has successfully established itself as a leading player in the diagnostics industry. One of the notable achievements includes its rapid expansion in the Chinese market, leading to a strong presence across the country. Dian Diagnostics Group Co Ltd has also made significant advancements in research and development, resulting in the launch of innovative diagnostic products and solutions. Additionally, the company has formed strategic partnerships with renowned medical institutions, facilitating collaborative efforts in research and improving healthcare outcomes. These milestones demonstrate Dian Diagnostics Group Co Ltd's commitment to growth, innovation, and delivering high-quality diagnostic services.

Dian Diagnostics Group Co Ltd is a renowned company in the healthcare sector. It was founded in 1992 in China and has since become a leading provider of medical diagnostic products and services. The company focuses on offering clinical testing and diagnostic solutions that aid in disease detection and treatment. With years of experience and expertise, Dian Diagnostics Group Co Ltd has developed a strong presence both domestically and internationally. They continue to innovate and expand their product portfolio to meet the evolving needs of the medical industry. Dian Diagnostics Group Co Ltd is committed to improving healthcare outcomes by delivering reliable and efficient diagnostic solutions.

The main competitors of Dian Diagnostics Group Co Ltd in the market are Company A, Company B, and Company C. These companies are also engaged in the diagnostics industry and offer similar products and services. Despite facing competition, Dian Diagnostics Group Co Ltd has established itself as a leading player in the market with its innovative solutions and strong customer relationships. With its commitment to quality and continuous improvement, the company has been able to stay ahead of its competitors and maintain a competitive edge in the industry.

Dian Diagnostics Group Co Ltd is primarily active in the healthcare industry.

Dian Diagnostics Group Co Ltd is a leading company in the healthcare industry. Its business model focuses on providing comprehensive diagnostic services to patients. The company operates a network of diagnostic centers and laboratories, offering a wide range of medical tests and examinations. Dian Diagnostics Group Co Ltd is committed to delivering accurate and timely results, enabling healthcare professionals to make informed decisions for their patients. With a strong emphasis on technological advancements and continuous research and development, the company strives to stay at the forefront of the diagnostics field. Dian Diagnostics Group Co Ltd's business model revolves around delivering high-quality healthcare services and contributing to the well-being of individuals and communities.

Dian Diagnostics Group Co hissesinin F/K oranı 12,96.

Dian Diagnostics Group Co KUV 0,54 dir.

Dian Diagnostics Group Co için AlleAktien Kalite Skoru 6/10'dur.

beklenen Dian Diagnostics Group Co cirosu 14,77 Milyar CNY dir.

beklenen Dian Diagnostics Group Co karı 611,58 Milyon. CNY olarak gerçekleşmiştir.

The Dian Diagnostics Group Co. Ltd is a leading Chinese company in the field of medical diagnostics and analysis. It was founded in 2002 and is headquartered in Hangzhou, China. Dian Diagnostics is listed on the Shenzhen Stock Exchange (Code: 300244.SZ) and has been on a rapid growth path for years. The business model of Dian Diagnostics includes various divisions, including laboratory diagnostics, clinical pathology, molecular diagnostics, biological banks, and medical research. The company offers a variety of products and services, including medical tests, diagnostic instruments, research and development services, as well as a wide range of reagents and consumables. Laboratory diagnostics is one of the main business areas of Dian Diagnostics. The company offers a wide range of tests that enable fast and accurate diagnosis. The tests include allergy tests, infection detection, tumor marker tests, and tests for chronic diseases such as diabetes and hypertension. Another important division of the company is clinical pathology, which specializes in the diagnosis of diseases and disorders of the physical condition. Dian Diagnostics offers differentiated diagnostic options to ensure fast and accurate diagnosis of metabolic diseases, rheumatic diseases, cancer, diabetes, and neurological disorders. They also offer services for analyzing disease allergies to identify allergens and thus alleviate the patient's symptoms. Molecular diagnostics is another business area of the company that specializes in the analysis of DNA and RNA samples, enabling targeted diagnosis of genetic diseases. Dian Diagnostics offers a wide range of molecular diagnostic tests, including tests for infectious diseases, cancer, genetic disorders, and reproductive health. Biological banks are another important area of Dian Diagnostics. The company offers secure and reliable storage of biological samples such as blood, cells, tissues, and genetic materials. These are used for medical research and the development of innovative diagnostic and therapy methods. In addition to the mentioned business areas, the company also offers imaging services, such as ultrasound examinations, X-rays, and MRI scans. Overall, the business model of Dian Diagnostics is diverse and covers many important areas of medical diagnostics and analysis. The company benefits from the high demand for medical tests, diagnostic instruments, and research and development services, and is well positioned to capitalize on the growing demand in the industry.

Dian Diagnostics Group Co, yılda kez dağıtılmak üzere 0,14 CNY tutarında temettü ödemektedir.

Dian Diagnostics Group Co için şu an için temettü hesaplanamıyor veya şirket temettü dağıtmıyor.

Dian Diagnostics Group Co şirketinin ISIN kodu CNE1000015N1’dir.

Dian Diagnostics Group Co için Ticker 300244.SZ’dir.

Son 12 ay içerisinde Dian Diagnostics Group Co, 0,20 CNY tutarında bir temettü ödedi. Bu, yaklaşık olarak 1,58 % oranında bir temettü verimine denk gelmektedir. Gelecek 12 ay için Dian Diagnostics Group Co, tahmini olarak 0,24 CNY tutarında bir temettü ödemesi yapacak.

Dian Diagnostics Group Co şirketinin mevcut temettü verimi 1,58 %.

Dian Diagnostics Group Co dönemsel olarak temettü ödemesi yapar. Bu ödemeler Temmuz, Temmuz, Haziran, Temmuz aylarında gerçekleştirilir.

Dian Diagnostics Group Co, son 15 yıl içerisinde her yıl temettü ödedi.

Önümüzdeki 12 ay için 0,24 CNY tutarında temettü ödenmesi beklenmektedir. Bu, 1,87 % oranında bir temettü verimidir.

Dian Diagnostics Group Co, 'Sağlık' sektörüne atanmıştır.

Son Dian Diagnostics Group Co tarihinde 0,06 CNY tutarındaki en son temettüyü alabilmek için, hisseyi 13.06.2024 tarihindeki Ex-Tag'den önce portföyünde bulundurman gerekiyordu.

Son ödeme tarihi 13.06.2024 olarak gerçekleşti.

2023 yılında Dian Diagnostics Group Co tarafından 0,135 CNY olarak temettüler dağıtıldı.

Dian Diagnostics Group Co hisselerinin temettüleri CNY olarak dağıtılır.